| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790367 | Urologic Oncology: Seminars and Original Investigations | 2017 | 6 Pages |
Abstract
ABO blood type was not associated with survival outcomes or incidences of serious AEs in mRCC patients treated with TKIs. However, blood type O may be associated with an increased number of disease sites.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kenji M.D., Shingo M.D., Tatsuyoshi M.D., Tsunenori M.D., Ph.D., Toshio M.D., Ph.D., Hiroki M.D., Kazunari M.D., Ph.D., Shunichi M.D., Ph.D.,